Just caught this on the wire - Marc Stapley, a director at Glaukos (GKOS), dumped fifteen thousand shares back in late January for roughly $1.9 million. That's a decent chunk of his holdings, actually. Went from 52k down to 37k shares after the sale.

What's interesting is this wasn't some random panic sell. The guy exercised stock options and immediately turned around and sold them the same day at $127.71 per share. Pretty calculated move, honestly. The filing shows it was all planned in advance under a Rule 10b5-1 trading plan, so no surprises there.

Glaukos is in the eye health space - glaucoma treatments and medical devices. They got FDA approval for re-administering one of their supplements in late January, which is bullish, but here's the thing: the company's been running at basically zero profit for years. Lost money again in 2025. Stock tanked about 25% last year, though it bounced back a few percent early this year.

Not sure what to make of an insider dumping shares while the company's still trying to turn things around, even with the FDA win. Could just be diversification or tax planning. But worth keeping an eye on if you're watching this one.